New Products: Device for temporary reduction of the appearance of cellulite
Noninvasive product is the first FDA-class II device cleared for temporary reduction of the appearance of cellulite.
Hello baby; bye-bye cellulite?
Helping women achieve their 'before baby body,' is the goal of VelaShape from Syneron Medical Ltd. (Yokneam, Israel). Could that be enough for some postpregnancy patients, even if VelaShape reduces the appearance of cellulite only temporarily?
The noninvasive product is the first FDA-class II device cleared for the temporary reduction of the appearance of cellulite-and also the first FDA-cleared device for the temporary reduction of thigh circumference, says Syneron.
A VelaShape treatment uses its elos technology (Electro-Optical Synergy), which combines infrared light energy and bipolar radiofrequency energy to send heat deeply into the tissue, with rollers to smooth the tissue. To download the study or see before and after photos, visit http://www.syneron.com/BAB.
Barriers in seeking pelvic floor disorder treatment among ethnic minorities
May 8th 2024A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Read More
Impact of weight, ferritin, and nutrition education on postpartum depression risk
May 7th 2024A recent study highlights the role of weight gain, ferritin levels, and nutritional education in influencing the risk of postpartum depression among pregnant women, urging for proactive measures during routine prenatal care.
Read More
